A combination of Korean mistletoe extract and resistance exercise retarded the decline in muscle mass and strength in the elderly: A randomized controlled trial

Exp Gerontol. 2017 Jan;87(Pt A):48-56. doi: 10.1016/j.exger.2016.11.003. Epub 2016 Nov 11.

Abstract

Given the increased concerns about the degenerative decline in the physical performance of the elderly, there is a need for developing effective strategies to suppress the age-related loss of skeletal muscle mass and functional capacity through a lifestyle intervention. This randomized controlled trial examined whether a combination of Korean mistletoe extract (KME) supplement and exercise affected muscle mass, muscle function, and targeted molecular expressions. Sixty-seven subjects aged 55-75years were assigned to placebo, low-dose (1g/d), or high-dose (2g/d) of KME for 12weeks. The body composition was significantly changed in the high-dose group during the intervention period as determined by skeletal muscle mass (P=0.040), fat free mass (P=0.042), soft lean mass (P=0.023), skeletal muscle index (P=0.041), fat-free mass index (P=0.030), percent body fat (P=0.044), and fat mass to lean mass ratio (P=0.030). Knee strength was measured by Cybex, demonstrating a significant effect in the KME groups compared to the placebo group (P=0.026 for peak torque and P=0.057 for set total work), which was more pronounced after adjusting for age, gender, protein, and energy intake (P=0.009 for peak torque and P=0.033 for set total work). The dynamic balance ability was remarkably improved in the high-dose group over a 12-week period as determined by Timed "Up and Go" (P=0.005 for fast walk test and P=0.024 for ordinary walk test). Consistent with these results, RT-PCR, multiplex analyses, and immunocytofluorescence staining revealed that a high-dose KME supplementation was effective for suppressing intracellular pathways related to muscle protein degradation, but stimulating those related to myogenesis. In particular, significant differences were found in atrogin-1 mRNA (P=0.002 at a single administration and P=0.001 at a 12-week administration), myogenin mRNA (P<0.0001 at a single administration and P=0.040 at a 12-week administration), and insulin growth factor 1 receptor phosphorylation (P=0.002 at a 12-week administration). These results suggest that KME supplementation together with resistance exercise may be useful in suppressing the age-related loss of muscle mass and strength in the elderly.

Keywords: Elderly; Mistletoe; Muscle biopsy; Muscle function; Muscle mass; Targeted gene analysis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Aging / drug effects*
  • Body Composition
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mistletoe / chemistry*
  • Muscle Proteins / genetics
  • Muscle Proteins / metabolism
  • Muscle Strength / drug effects*
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / physiology*
  • Organ Size / drug effects
  • Plant Extracts / pharmacology*
  • RNA, Messenger / analysis
  • Receptor, IGF Type 1
  • Receptors, Somatomedin / genetics
  • Receptors, Somatomedin / metabolism
  • Republic of Korea
  • SKP Cullin F-Box Protein Ligases / genetics
  • SKP Cullin F-Box Protein Ligases / metabolism
  • Sarcopenia / drug therapy*

Substances

  • IGF1R protein, human
  • Muscle Proteins
  • Plant Extracts
  • RNA, Messenger
  • Receptors, Somatomedin
  • FBXO32 protein, human
  • SKP Cullin F-Box Protein Ligases
  • Receptor, IGF Type 1